Sarcoidosis, a relatively uncommon disease, is rarely encountered by disability assessors, leading to a knowledge gap regarding its impact. Patients frequently express dissatisfaction with work capacity assessments, which often do not include input from sarcoidosis experts and tend to focus narrowly on lung function tests. In addition to the highly variable spectrum of organ-related disabilities, functional impairments, including fatigue, reduced exercise capacity, and cognitive impairment, cause complex disruptions across crucial life domains such as ability to work. Difficulties arise when assessing such elusive manifestations that do not have straightforward evaluation and quantitative tests. This Comment, informed primarily by patients with first-hand experience worldwide, patient advocate groups, clinicians, and the literature, offers a better understanding of the impact of sarcoidosis on the ability to work, and a more realistic approach to the quantification of disease burden.

Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis

Confalonieri, Marco
Membro del Collaboration Group
;
Confalonieri, Paola
Membro del Collaboration Group
2024-01-01

Abstract

Sarcoidosis, a relatively uncommon disease, is rarely encountered by disability assessors, leading to a knowledge gap regarding its impact. Patients frequently express dissatisfaction with work capacity assessments, which often do not include input from sarcoidosis experts and tend to focus narrowly on lung function tests. In addition to the highly variable spectrum of organ-related disabilities, functional impairments, including fatigue, reduced exercise capacity, and cognitive impairment, cause complex disruptions across crucial life domains such as ability to work. Difficulties arise when assessing such elusive manifestations that do not have straightforward evaluation and quantitative tests. This Comment, informed primarily by patients with first-hand experience worldwide, patient advocate groups, clinicians, and the literature, offers a better understanding of the impact of sarcoidosis on the ability to work, and a more realistic approach to the quantification of disease burden.
2024
16-ott-2024
Pubblicato
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2213260024002972-main.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 389.82 kB
Formato Adobe PDF
389.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S2213260024002972-mmc1.pdf

Accesso chiuso

Tipologia: Altro materiale allegato
Licenza: Digital Rights Management non definito
Dimensione 222.49 kB
Formato Adobe PDF
222.49 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3095838
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact